Results 121 to 130 of about 393,422 (164)

Erratum: <i>FTO</i>-induced <i>APOE</i> promotes the malignant progression of pancreatic neuroendocrine neoplasms through <i>FASN</i>-mediated lipid metabolism: Erratum. [PDF]

Int J Biol Sci
Chen J, Ye M, Gu D, Yu P, Xu L, Xue B, Yan L, Lu F, Hu C, Xu Y, Shi X, Chen L, Wang Y, Bai J, Tian Y, Tang Q.   +15 more
europepmc   +1 more source

Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan. [PDF]

J Cancer
Ho WP, Chou WC, Hsieh CH, Hou MM, Shen WC, Huang PW, Wu CE, Hsu CC, Chang WC, Kuo YC, Hsu HC, Chang CF, Su PJ, Wu RC, Chen JS, Huang WK.   +15 more
europepmc   +1 more source

Laparoscopic enucleation vs. pancreatectomy for small pancreatic neuroendocrine neoplasms: long-term functional and oncological outcomes. [PDF]

Surg Endosc
Miura T, Aoki S, Maeda S, Ishida M, Mizuma M, Kume K, Murakami K, Masamune A, Furukawa T, Kamei T, Unno M.   +10 more
europepmc   +1 more source

Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms. [PDF]

Curr Oncol
Masciangelo G, Campana D, Ricci C, Andrini E, Rakichevikj E, Fusaroli P, Lisotti A.   +6 more
europepmc   +1 more source

Comparative analysis of streptozocin-based regimen and capecitabine-temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index. [PDF]

Ther Adv Med Oncol
Tabe Y, Ono H, Matsui S, Asano D, Ishikawa Y, Ueda H, Akahoshi K, Katsuta E, Ban D.   +8 more
europepmc   +1 more source

Intraoperative hepatic ultrasonography in patients with gastrointestinal and pancreatic neuroendocrine neoplasms without preoperative evidence of liver metastases. [PDF]

J Neuroendocrinol
Viganò L, Maruccio M, Faustini F, Frigerio I, Gavazzi F, De Robertis Lombardi R, Scopelliti F, Capretti G, Ammirabile A, D'Onofrio M, Giardino A, Ferrillo G, Rodari M, Regi P, Procopio F, Salvia R, Lania A, Butturini G, Landoni L, Torzilli G, Zerbi A.   +20 more
europepmc   +1 more source

Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations. [PDF]

JCO Oncol Adv
Azar I, Khan HY, Bannoura SF, Gandhi N, Uddin MH, Nagasaka M, Gong J, Nazha B, Choucair K, Vojjala N, Khushman MM, Soares HP, El-Deiry WS, Philip PA, El-Rayes B, Chen H, Lou E, Muqbil I, Farrell AP, Swensen J, Oberley MJ, Nabhan C, Goel S, Shields AF, Mohammad RM, Pasche BC, Azmi AS.   +26 more
europepmc   +1 more source

Histopathological features of gastrointestinal and pancreatic neuroendocrine neoplasms: An 11-year retrospective study from a tertiary center in Saudi Arabia. [PDF]

Saudi Med J
Bokhary RY.
europepmc   +1 more source

Differentiation of non-hypervascular non-functional pancreatic neuroendocrine neoplasms from solid pseudopapillary neoplasms using dual-layer spectral detector CT. [PDF]

BMC Med Imaging
Yuan J, Chen M, Liu J, Wang L, Zhang M, Zhang N, Feng ST, Wei L, Shi S, Luo Y.   +9 more
europepmc   +1 more source

Roadmap to Challenges in Limited Cellularity Specimens from Pancreatic Neuroendocrine Neoplasms: Diagnostic Tools for the Most Appropriate Management of Limited Material. [PDF]

Endocr Pathol
La Rosa S, Maragliano R, Marchiori D.
europepmc   +1 more source